Cliical Trials: Statistical Data Surveillance

Documenting Statistical Surveillance Methods in Protocol and SAP Documenting Statistical Surveillance Methods in Protocol and SAP Statistical surveillance is a critical component in ensuring the integrity and validity of clinical trial data, particularly in the conduct of sma clinical trials. Proper documentation of statistical surveillance methods in both the Trial Protocol and Statistical Analysis Plan…

Read More “Documenting Statistical Surveillance Methods in Protocol and SAP” »

Surveillance in DCT and eSource-Heavy Trials With High-Volume Data Surveillance in DCT and eSource-Heavy Trials With High-Volume Data The integration of Digital Clinical Trials (DCT) and eSource methodologies has transformed the landscape of clinical research, particularly for trials involving high-volume data. This article serves as a comprehensive tutorial aimed at clinical operations, regulatory affairs, and…

Read More “Surveillance in DCT and eSource-Heavy Trials With High-Volume Data” »

Tools and Platforms for Automated Statistical Data Surveillance Tools and Platforms for Automated Statistical Data Surveillance The landscape of clinical trials is evolving, particularly in the realm of statistical data surveillance. In recent years, technologies and methodologies have emerged to allow for effective remote monitoring and oversight of clinical trials, including those focusing on ankylosing…

Read More “Tools and Platforms for Automated Statistical Data Surveillance” »

Case Studies: Surveillance-Driven Interventions That Protected Patients Case Studies: Surveillance-Driven Interventions That Protected Patients The landscape of clinical trials is continually evolving, particularly with the rise of surveillance-driven interventions that are crucial for protecting patient safety and data integrity. This guide provides a comprehensive overview of the effective implementation of these interventions in the context…

Read More “Case Studies: Surveillance-Driven Interventions That Protected Patients” »

Building Surveillance Capability in Lean Clinical Development Teams In the context of modern clinical trials, particularly those governed by ICH-GCP, FDA, EMA, and MHRA regulations, the need for robust surveillance capabilities has never been more critical. In this guide, we will delve into how to build surveillance capability within lean clinical development teams, focusing on…

Read More “Building Surveillance Capability in Lean Clinical Development Teams” »

Working With Biostatistics and Data Science Teams on Surveillance Design The design and execution of clinical trials require meticulous planning, robust statistical analysis, and seamless collaboration between various teams, particularly when it involves pivotal studies such as the lecanemab clinical trial. Biostatistics and data science teams play crucial roles in the surveillance design of clinical…

Read More “Working With Biostatistics and Data Science Teams on Surveillance Design” »